ArticleJournal of the Chinese Medical Association : JCMA2020
Ultrasound-guided dextrose injection treatment for chronic myofascial pain syndrome: A retrospective case series.
Article in Journal of the Chinese Medical Association : JCMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05429827 (The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome), which is not on this map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
Who cites it
8 citing papers in PubMed, 18 citations in OpenAlex.
- Platelet-Rich Plasma Versus Polydeoxyribonucleotide for Myofascial Pain Syndrome and Musculoskeletal Disorders: A Narrative Review of Mechanisms, Clinical Evidence, and Translational Considerations.Bioengineering (Basel, Switzerland) · 2026Review
- Comparison of the short-term effectiveness of myofascial dextrose injection and radial extracorporeal shockwave therapy in myofascial pain syndrome: A prospective, randomized clinical study.Turkish journal of physical medicine and rehabilitation · 2026Article
- The Effect of 5-in-1 Dextrose Neural Prolotherapy for Periscapular Myofascial Pain Syndrome: A Retrospective Study.Cureus · 2025Article
- Ultrasound-guided injection of platelet-rich plasma alleviated pain and improved function for individuals with myofascial pain syndrome: a retrospective case series study.BMC musculoskeletal disorders · 2025Article
- A Prospective Nonrandomized Comparison of Wet Needling Versus Prolotherapy in Myofascial Pain.Cureus · 2024Article
- Effects of platelet-rich plasma injection on electrical activity and biomechanics of the erector spinae muscles in lumbar myofascial pain syndrome.Scientific reports · 2024Article
- Add-on therapy of interfascial hydrodissection to trigger point injection for myofascial pain?Journal of the Chinese Medical Association : JCMA · 2021Article
- Posterior Hip Pain: Ultrasound Imaging/Guidance for Piriformis Syndrome.Journal of medical ultrasoundArticle
Corrections and comments
- Commented on by
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDue to the lack of an evidence-based consensus, managing refractory myofascial pain syndrome is challenging for clinicians. Dextrose injection (dextrose prolotherapy) emerged as a promising, cost-effective treatment. This study evaluated the efficacy of targeted ultrasound-guided dextrose injection for localized myofascial pain syndrome.
methodsWe retrospectively reviewed the clinical outcomes of 45 patients with myofascial pain syndrome refractory to alternative treatments with targeted ultrasound-guided dextrose injection. Pretreatment symptom severity and symptomatic response 1 month after treatment were statistically analyzed using a visual analog scale (VAS)-based scoring system.
resultsOf 45 patients, 8 (24.4%) reported complete resolution of symptoms at the treated site. In total, 36 (80.0%) patients reported greater than 50% improvement in their symptoms. The mean pretreatment and posttreatment VAS scores were 7.0 and 2.44 (p < 0.001), indicating an overall 65.0% reduction in symptom severity.
conclusionTargeted ultrasound-guided dextrose injection was remarkably effective for refractory localized myofascial pain syndrome, significantly reducing symptom intensities in the majority of treated patients within 1 month after a single injection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.